[1]方继伟, 范建高.非酒精性脂肪性肝病的治疗现状[J].中华肝脏病杂志, 2003, 11 (2) ∶120-122.
|
[2]Juergen S, Peter R G.Treatment of nonalcoholic fatty liverdisease[J].World J Gastroenterol, 2006, 12 (14) ∶2161-2167.
|
[3]刘协, 顾呈华, 胡启之, 等.甘草甜素脂质体对小鼠急性酒精性肝损伤的保护作用[J].中国临床康复, 2004, 8 (36) ∶8260-8261。
|
[4]马中春.甘草甜素对四氯化碳诱发大鼠肝脏损伤的作用及其机制[J].毒理学杂志, 2005, 19 (3) ∶250-251.
|
[5]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) ∶161-163.
|
[6]李祖惠, 杨辉.脂质体药物研究进展[J].中国药业, 2005, 14 (10) ∶75-76.
|
[1] | Haiyang ZHU, Jingshu CUI, Liu YANG, Mengting ZHOU, Jian TONG, Hongmei HAN. Mechanism of 1,25(OH)2D3 improving liver inflammation in a rat model of nonalcoholic steatohepatitis induced by choline-deficient L-amino acid-defined diet[J]. Journal of Clinical Hepatology, 2025, 41(2): 254-262. doi: 10.12449/JCH250210 |
[2] | Yijing XIN, Yiyun CHEN, Hailin YANG, Yunhui ZHUO, Dingqi ZHANG, Fengfeng ZHOU. Effect of Xuanfuhua decoction on a mouse model of nonalcoholic steatohepatitis induced by high-fat, high-fructose, and high-cholesterol diet[J]. Journal of Clinical Hepatology, 2023, 39(6): 1340-1350. doi: 10.3969/j.issn.1001-5256.2023.06.014 |
[3] | Zhenyang SHEN, Xiaobo CAI, Lungen LU. Application of farnesoid X receptor agonists in treatment of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2022, 38(6): 1402-1405. doi: 10.3969/j.issn.1001-5256.2022.06.038 |
[4] | Yu WANG, Xuebing YAN. Advances in phase Ⅲ drug studies on the pipeline in nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2022, 38(6): 1398-1401. doi: 10.3969/j.issn.1001-5256.2022.06.037 |
[5] | Yingshuo HUANG, Wei WEI, Xiaofei TONG, Yameng SUN, Jianxiong ZHANG, Ruihua DONG, Jidong JIA, Hong YOU. Clinical trial protocols of new drugs for nonalcoholic steatohepatitis: A systematic review[J]. Journal of Clinical Hepatology, 2022, 38(4): 798-804. doi: 10.3969/j.issn.1001-5256.2022.04.012 |
[6] | Yingshuo HUANG, Ruihua DONG, Hong YOU. Difficulties and challenges in the clinical trial of new drugs for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1948-1952. doi: 10.3969/j.issn.1001-5256.2021.08.044 |
[7] | Xinyu AN, Lingxi HU, Jie QIAO, Rongqi WANG, Yuemin NAN. Role of microRNAs in the development and progression of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2963-2966. doi: 10.3969/j.issn.1001-5256.2021.12.048 |
[8] | QIAN ShuaiJie, GU JingYue, GAO JinHang, TONG Huan. Advances in therapeutic drugs for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2826-2830. doi: 10.3969/j.issn.1001-5256.2020.12.039 |
[9] | Chen Jun, Li LiangPing, Fu WanZhi. Value of microparticles in the diagnosis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2019, 35(9): 2026-2031. doi: 10.3969/j.issn.1001-5256.2019.09.028 |
[10] | Jiang Yu, Hu JuLong, Ma JiaLi, Li Ping, Zhou YuLing, Liang XiuXia, Ai ZhengLin, Yao ShuKun. Antioxidant effect of berberine in a rat model of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1273-1276. doi: 10.3969/j.issn.1001-5256.2018.06.028 |
[11] | Mao YiMin. Clinical trials of investigational new drugs for nonalcoholic steatohepatitis:challenges in design and practice[J]. Journal of Clinical Hepatology, 2017, 33(12): 2292-2295. doi: 10.3969/j.issn.1001-5256.2017.12.007 |
[12] | Hu MengQi, Xu YouQing, Zhang Tao, Xu HongTuan. Research advances in noninvasive diagnostic methods for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(12): 2288-2291. doi: 10.3969/j.issn.1001-5256.2017.12.006 |
[13] | Mai JingYin, Chen TianYang, Cheng Yang. Changes in microRNA expression profile in the liver of mice with nonalcoholic fatty liver disease induced by high-fat diet[J]. Journal of Clinical Hepatology, 2017, 33(12): 2372-2375. doi: 10.3969/j.issn.1001-5256.2017.12.023 |
[14] | Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272. |
[15] | Huang Ning, Wu WanChun. The effect of low iron loads on Nonalcoholic Steatohepatitis in rats[J]. Journal of Clinical Hepatology, 2009, 25(6): 427-430. |
[16] | Xu Hui, Wen QinSheng, Wang XuXia, Zhang YaFei, Li Jun, Gu BingQuan. The effect of cimetidine on the blood sugar, serum insulin and other indexes in NASH rats[J]. Journal of Clinical Hepatology, 2007, 23(2): 112-114. |
[19] | Dai Lin, Deng Bin, Li AiPing, Yu HongBo, Bai Cheng, Lu ShengMing. Experimental study on the pathogenesis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2004, 20(5): 285-286. |